Nuvation Bio Inc. (NUVB) stock forecast and price target
Price $3.99 · data as of November 13, 2026
12-month price target
Average target$12.45
Upside / downside+212.1%
Analysts11
ConsensusStrong buy
Low $7.00Average $12.45High $21.00
Gold marker: average target · white marker: today’s price ($3.99)
Analyst ratings
Strong buy 3Buy 9Hold 1Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-0.29 | +41.3% | $203M |
| Next fiscal year ends December 31, 2027 | $-0.08 | +72.4% | $251M |
| Next quarter ends December 31, 2026 | $-0.10 | −10.5% | $43M |
| Quarter after ends March 31, 2027 | $-0.06 | — | $57M |
Consensus of the analysts covering Nuvation Bio, updated daily. In the last 30 days 0 estimates were raised and 1 lowered.
Frequently asked questions
What is the Nuvation Bio stock price target?
The average 12-month target from 11 analysts is $12.45, 212.1% above the current price of $3.99 Targets range from $7.00 to $21.00.
Is Nuvation Bio a buy according to analysts?
The consensus rating is “Strong buy” (3 strong buy, 9 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Nuvation Bio expected to earn?
Analysts expect EPS of $-0.29 for the fiscal year ending December 31, 2026 and $-0.08 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.